What is Azure Biosystems?
Azure Biosystems, based in California, is a life science company focused on developing and commercializing advanced instruments and reagents for research. Their product portfolio includes high-quality imaging systems, qPCR systems, and reagents for cell analysis, genomics, and protein biology. The company's mission is to offer affordable solutions that enhance the research capabilities of scientists and laboratories, serving academic institutions and research organizations dedicated to scientific discovery.
How much funding has Azure Biosystems raised?
Azure Biosystems has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Azure Biosystems
PPP
Public-Private Partnership
What's next for Azure Biosystems?
With a large-scale, late-stage funding context, Azure Biosystems is positioned for significant scaling and market expansion. The recent strategic investment suggests a focus on accelerating product development, enhancing commercialization efforts, and potentially broadening its market reach. This capital infusion will likely enable the company to further solidify its offerings in imaging, genomics, and protein biology, aiming to capture a larger share of the life science research market.
See full Azure Biosystems company page
